Reliq Health Technologies Inc., a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has entered into an engagement agreement with Canaccord Genuity Corp. and Gravitas Securities Inc. to act as co-lead agents on a commercially reasonable efforts basis in respect to a brokered private placement offering of up to 10,000,000 units at a price of $0.40 per Unit for gross proceeds of up to $4,000,000 subject to completion of satisfactory due diligence. Each Unit will consist of one common share in the capital of the Company and one-half transferable common share purchase warrant (each whole warrant, a “Warrant”), with each Warrant exercisable into one additional Share at a price of $0.60 for a period of two years from the date of closing. The Company intends to use the net proceeds of the offering for general working capital, product development and customer acquisition.
“We are delighted to have two of Canada’s leading independent brokerage firms support the Company,” said Dr. Lisa Crossley, CEO of Reliq.